Wendy K. Chung, M.D., Ph.D.
Board Member
Rallybio Corp (RLYB)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Wendy K. Chung, M.D., Ph.D.
Wendy K. Chung, M.D., Ph.D. is recorded as Board Member at Rallybio Corp (RLYB). Rallybio Corp reported in an 8-K filed August 2, 2022 that Wendy K. Chung, M.D., Ph.D. was appointed director, effective August 1, 2022.
“On August 1, 2022, upon the recommendation of the Nominating and Corporate Governance Committee of the Board of Directors (the Board) of Rallybio Corporation (Rallybio), the Board increased its size from nine directors to ten directors and appointed Wendy K. Chung, M.D., Ph.D. to serve as a director to fill the newly created vacancy, effective August 1, 2022.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-08-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Rallybio Corp
Other people whose current roles at this company are on record from its filings.
- Athena Countouriotis, M.D. CEO
- Stephen Uden CEO, COO, Board Member
- Stephen Uden, M.D. CEO, Board Member
- Martin Mackay, Ph.D. Chairman
- Jonathan I. Lieber CFO
- Scott Lipman, M.B.A. CFO
- Brian Sun, J.D. General Counsel
- Christine A. Nash Board Member
- Helen M. Boudreau Board Member
- Hui Liu Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.